Redefining Standards
Please log in for more information
Log in or register to read this article in full and gain access to The Pathologist’s entire content archive. It’s FREE!
Horizon Discovery Group PLC is a world leader in the utilization of gene editing and gene modulation technologies to support the greater understanding of gene function, the genetic drivers behind human disease and the development of personalized molecular, cell and gene therapies.
The company’s products and services are used by thousands of scientists working in academic institutes, pharmaceutical companies and clinical diagnostic laboratories around the globe. Horizon is headquartered in Cambridge, UK.